- About Us
- Guidelines
-
The Author ensures that the research has been conducted responsibly and ethically with adherence to all relevant regulations. read more..
- For Authors
- For Reviewer
- Manuscript Guidelines
- Membership
- Publication Ethics
-
- Journals
- Reprints
- e-Books
- Videos
- Indexing
- Contact Us
COVID-19
- Submissions
Abstract
Advancements in Case Studies
Allogeneic Chimeric Antigen Receptor T Cells: A Further Potential Weapon for Haematological Malignancies
-
Open or CloseMartina Canichella1* and Paolo de Fabritiis1,2
1Haematology, St. Eugenio Hospital, ASL Roma, Italy
2Department of Biomedicina e Prevenzione, Tor Vergata University, Italy
*Corresponding author:Martina Canichella, UOC Ematologia, St. Eugenio Hospital, Piazzale dell’Umanesimo 10, 00144 Rome, Italy
Submission:May 17, 2023; Published: June 13, 2023
ISSN 2639-0531Volume4 Issue1
Editor In Chief
.jpg)
Signup for Newsletter
Quick Links
Editorial Board Registrations
Submit your Article
Best Paper of the Volume
Reprints
Refer a Friend
Advertise With UsOur Recent Edition
.jpg)
Top Editors
.jpg)
.bmp)
.jpg)
.png)
.jpg)
.jpg)
.png)
.png)
.png)
Financial Support
Sponsors
Latest e-Books
Latest Video
© 2017 Crimson Publishers, All rights reserved. No part of this content may be reproduced or transmitted in any form or by any means as per the standard guidelines of fair use.
Creative Commons License Open Access by Crimson Publishers is licensed under
a Creative Commons Attribution 4.0 International License. Based on a work at www.crimsonpublishers.com.
Best viewed in 
| Above IE 9.0 version
a Creative Commons Attribution 4.0 International License. Based on a work at www.crimsonpublishers.com.
Best viewed in
| Above IE 9.0 version